A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Biogen Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 22,471 shares of BIIB stock, worth $3.91 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,471
Previous 26,211 14.27%
Holding current value
$3.91 Million
Previous $5.65 Million 7.82%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$190.52 - $236.72 $712,544 - $885,332
-3,740 Reduced 14.27%
22,471 $5.21 Million
Q1 2024

May 15, 2024

SELL
$212.02 - $267.71 $2.13 Million - $2.69 Million
-10,054 Reduced 27.72%
26,211 $5.65 Million
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $365,937 - $440,493
1,644 Added 4.75%
36,265 $9.38 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $358,419 - $404,534
1,415 Added 4.26%
34,621 $8.9 Million
Q2 2023

May 17, 2024

BUY
$275.25 - $318.06 $1.93 Million - $2.22 Million
6,995 Added 26.69%
33,206 $9.46 Million
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $2.5 Million - $2.89 Million
9,080 Added 37.64%
33,206 $9.46 Million
Q1 2023

May 17, 2024

SELL
$256.56 - $292.34 $9.25 Million - $10.5 Million
-36,045 Reduced 59.9%
24,126 $6.71 Million
Q1 2023

May 15, 2023

SELL
$256.56 - $292.34 $9.25 Million - $10.5 Million
-36,045 Reduced 59.9%
24,126 $6.71 Million
Q4 2022

May 17, 2024

BUY
$252.44 - $306.72 $8.57 Million - $10.4 Million
33,960 Added 129.56%
60,171 $16.7 Million
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $1.55 Million - $1.88 Million
6,129 Added 11.34%
60,171 $16.7 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $4.99 Million - $6.88 Million
25,641 Added 90.28%
54,042 $14.4 Million
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $2.14 Million - $2.54 Million
11,400 Added 67.05%
28,401 $5.79 Million
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $3.01 Million - $3.87 Million
-13,445 Reduced 44.16%
17,001 $4.08 Million
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $2.06 Million - $2.69 Million
-7,288 Reduced 19.31%
30,446 $8.62 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $2.35 Million - $3.76 Million
9,065 Added 31.62%
37,734 $13.1 Million
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $4 Million - $4.68 Million
-16,457 Reduced 36.47%
28,669 $8.02 Million
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $13.9 Million - $21 Million
-58,976 Reduced 56.65%
45,126 $11 Million
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $10.4 Million - $12.1 Million
-39,425 Reduced 27.47%
104,102 $29.5 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $17 Million - $22.5 Million
65,594 Added 84.17%
143,527 $38.4 Million
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $18.7 Million - $23.7 Million
-69,522 Reduced 47.15%
77,933 $24.7 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $7.47 Million - $10.3 Million
-33,934 Reduced 18.71%
147,455 $43.7 Million
Q3 2019

Nov 14, 2019

SELL
$217.44 - $243.88 $3.51 Million - $3.94 Million
-16,157 Reduced 8.18%
181,389 $42.2 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $7.81 Million - $8.61 Million
-35,636 Reduced 15.28%
197,546 $46.2 Million
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $110 Million - $173 Million
-509,117 Reduced 68.59%
233,182 $55.1 Million
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $41.2 Million - $52.1 Million
-147,775 Reduced 16.6%
742,299 $218 Million
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $17.6 Million - $23 Million
59,889 Added 7.21%
890,074 $0
Q2 2018

Apr 15, 2019

BUY
$257.52 - $306.91 $331,428 - $394,993
1,287 Added 0.16%
830,185 $241 Million
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $24.3 Million - $28.9 Million
94,239 Added 12.83%
828,898 $241 Million
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $205,242 - $290,280
-789 Reduced 0.11%
734,659 $201 Million
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $90.1 Million - $101 Million
-292,979 Reduced 28.49%
735,448 $234 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $289 Million - $339 Million
1,028,427
1,028,427 $322 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Portfolio

Follow Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.